Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...
Christopher Toral, a former ICE deportation officer, pleaded guilty in federal court Thursday to charges of money laundering.
Following an inspection of Piramal’s production facility in Maharashtra, India, that ran from Feb. 11 to Feb. 17, the FDA slapped the company with six-observation Form 483 detailing shortfalls ...
38,858 people played the daily Crossword recently. Can you solve it faster than others?38,858 people played the daily Crossword recently. Can you solve it faster than others? Hunter Schafer’s ...
38,858 people played the daily Crossword recently. Can you solve it faster than others?38,858 people played the daily Crossword recently. Can you solve it faster than others?
In the medical device industry, the stakes of an FDA inspection are high. Non-compliance can lead to delayed market access, product recalls, or regulatory actions that can jeopardize a company’s ...
We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...
The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted.
Orchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India ... The company has successfully completed a USFDA inspection at its Active ...
announced the successful completion of a surprise US Food and Drug Administration (FDA) inspection at its active pharmaceutical ingredient (API) manufacturing facility in Alathur, Tamil Nadu. The ...
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May 30, 2024 to June 7, 2024, including manufacturing and ...
The company also was cited for refusing entry to FDA inspectors on March 15, 2024. The agency’s team was eventually granted permission to enter the facility on March 20, however, inspectors said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results